OBOrit Blumenfeld

Orit Blumenfeld

*This is an algorithmically generated author record based on publicly available information.

Orit Blumenfeld has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of COVID-19 vaccination on 30-day mortality after cardiac surgery – Insights from the Israel national registries

    by Orit Blumenfeld, Alina Rosenberg, Michal Reuven, Inbar Caspi, Erez Sharoni, Dror B. Leviner


  • Quality of Life, Depression, and Food Tolerance, After Primary Sleeve Gastrectomy Among Israeli Patients: A Cross-Sectional National Study

    by Orit Blumenfeld, Alina Rosenberg, Yael Friedman, Sergio Gabriel Susmallian, Lital Keinan-Boker, David Goitein

    Background: Adequate data on quality-of-life (QoL) after sleeve gastrectomy (SG) is scarce. Our aim was to study QoL, depression, and food tolerance after primary SG. Methods: Validated, well-accepted questionnaires targeting QoL (36-Item Short Form Survey Instrument [SF-36], Moorehead-Ardelt Quality of Life II (MA II), depression (Center for Epidemiologic Studies Depression Scale [CES-D]), and food tolerance (food tolerance score [FTS]) were administered to two distinct cohorts: “Operated”: A random sample of patients who underwent primary SG, “Candidate”: Candidates for primary bariatric surgery. Results: The “operated” cohort included 160 patients. Mean time from surgery and mean age were 4.4 ± 0.3 and 44.9 ± 12.1 years, respectively. Sixty two percent were female. The “candidate” cohort included 517 patients with a mean age of 38.1 ± 11.9 years, 75% of which were female. All participants completed the questionnaires (N = 677). Physical function QoL scores in the “operated” and “candidate” cohorts were 76.6 ± 14.9 and 58.2 ± 20.1 (p < 0.0001), respectively, for SF-36 and 0.08 ± 0.3 and −0.01 ± 0.3 (p < 0.0001), respectively, for MA II. Mental health scores in the “operated” and the “candidate” cohorts were 74.7 ± 15.2 and 64.1 ± 19.4 (p < 0.0001), respectively. The “operated” cohort scored better on the CES-D but worse on FTS (p < 0.0001 for both). Conclusion: Patients undergoing SG surgery report better QoL scores 4–5 years following the procedure than candidates. However, bariatric surgery candidates report better FTSs. Clinical Trial Registration Number: #NOH-161-2017.


  • Do Mechanically Ventilated COVID-19 Patients Present a Higher Case-Fatality Rate Compared With Other Infectious Respiratory Pandemics? A Systematic Review and Meta-Analysis

    by Orit PhD Blumenfeld, Shai Md Fein, Asaf Miller, Yael Msc Hershkovitz, Inbar Caspi, Yaron Niv, Lital Keinan-Boker

    Background Early reports on COVID-19 patient outcomes showed a marked fatality rate among patients requiring invasive mechanical ventilation (IMV). Objective Our aim was to compare case fatality rate (CFR) outcomes for patients requiring IMV due to severe acute respiratory syndrome (SARS)-associated coronavirus 2 (COVID-19), SARS-associated coronavirus 1, Middle East respiratory syndrome (MERS), and influenza (H1N1). Materials and Methods We searched PubMed, EMBASE, MEDLINE, Google Scholar, and Cochrane Library for relevant studies published between December 2019 and April 2021 for COVID-19, between January 2002 and December 2008 for SARS, between January 2012 and December 2019 for MERS, and between January 2009 and December 2016 for influenza (H1N1). Results Overall, this study included 81 peer-reviewed studies, pertaining to 65,058 patients requiring IMV: 61 studies including 62,809 COVID-19 patients, 4 studies including 148 SARS patients, 9 studies including 875 MERS patients, and 7 studies including 1226 influenza (H1N1) patients. The CFR for COVID-19 patients requiring IMV was not significantly different from the CFR for SARS and influenza (H1N1) patients (45.5% [95% confidence interval (CI), 38.5%–52.8%] vs. 48.1% [95% CI, 39.2%–57.2%] and 39.7% [95% CI, 29.3%–51.3%], respectively). However, CFR for COVID-19 patients was significantly lower compared with that for MERS patients (CFR, 70.6%; 95% CI, 60.9%–78.8%). Conclusions COVID-19 patients requiring IMV show a similar CFR compared with SARS and H1N1 influenza patients but a lower CFR compared with MERS patients. To improve survival in future pandemics, we recommend examining the pros and cons of the liberal use of endotracheal intubation and considering drafting guidelines for the selection of patients to intubate and the timing of intubation.


  • Open Access

    Validation of the society of thoracic surgeons predicted risk of mortality score for long-term survival after cardiac surgery in Israel

    by Eyal I. Ben-David, Orit Blumenfeld, Ayelet Shapira-Daniels, Oz M. Shapira

    Background: Long-term survival is an important metric in assessing procedural value. We previously confirmed that the Society of Thoracic Surgeons predicted risk of mortality score (PROM) accurately predicts 30-day mortality in Israeli patients. The present study investigated the ability of the PROM to reliably predict long-term survival.Methods: Data on 1279 patients undergoing cardiac surgery were prospectively entered into our database and used to calculate PROM. Long-term mortality was obtained from the Israeli Social Security Database. Patients were stratified into five cohorts according to PROM (A: 0–0.99%, B: 1.0–1.99%, C: 2.0–2.99%, D: 3.0–4.99% and E: ≥ 5.0%). Kaplan–Meier estimates of survival were calculated for each cohort and compared by Wilcoxon signed-rank test. We used C-statistics to assess model discrimination. Cox regression analysis was performed to identify predictors of long-term survival.Results: Follow-up was achieved for 1256 (98%) patients over a mean period of 62 ± 28 months (median 64, range 0–107). Mean survival of the entire cohort was 95 ± 1 (95% CI 93–96) months. Higher PROM was associated with reduced survival: A—104 ± 1 (103–105) months, B—96 ± 2 (93–99) months, C—93 ± 3 (88–98) months, D—89 ± 3 (84–94) months, E—74 ± 3 (68–80) months (p < 0.0001). The Area Under the Curve was 0.76 ± 0.02 indicating excellent model discrimination. Independent predictors of long-term mortality included advanced age, lower ejection fraction, reoperation, diabetes mellitus, dialysis and PROM.Conclusions: The PROM was a reliable predictor of long-term survival in Israeli patients undergoing cardiac surgery. The PROM might be a useful metric for assessing procedural value and surgical decision-making.


  • Outcomes of cardiac surgery in patients with end‐stage renal disease: Insights from the Israel national registries

    by Orit Blumenfeld, Rita Dichtiar, Erez Sharoni, Dror B. Leviner

    Background End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. Methods The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. Results One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2–18.2), MVR procedure (HR = 1.5, 95% CI; 1.04–2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2–2.04). Conclusions Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.


  • The Israel National Bariatric Surgery Registry: the inception process

    by Orit Blumenfeld, David Goitein, Sigal Liverant-Taub, Dror Diker, Nasser Sakran, Lital Keinan-Boker


  • Comparative Effectiveness of Laparoscopic Adjustable Gastric Banding vs Laparoscopic Sleeve Gastrectomy in Adolescents—a National Registry-Based Study

    by Orit Blumenfeld, Nahum Beglaibter, Nissim Geron, Rita Dichtiar, David Hazzan, Lital Keinan-Boker, David Goitein

    Most published work on bariatric surgery (BS) in adolescents describes outcomes after laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass. We compared the efficacy of LAGB and laparoscopic sleeve gastrectomy (LSG) in adolescents.


  • Prevalence of cerebral palsy with Gross Motor Function Classification System levels IV and V in children in Israel: a cross-cultural comparison

    by Orit Blumenfeld, Hilla Ben-Pazi, Asher Ornoy, Adina Josef, Tamy Shohat

    Cerebral palsy is the most common physical disability in childhood. Our aim was to study the prevalence of wheelchair-dependent cerebral palsy (equivalent to gross motor function classification system level IV/V) among Jewish and Arab children in Israel and to investigate differences between the children of the two population groups.


  • Correction to: Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study

    by Nasser Sakran, Shiri Sherf-Dagan, Orit Blumenfeld, Orly Romano-Zelekha, Asnat Raziel, Dean Keren, Itamar Raz, Dan Hershko, Ian M. Gralnek, Tamy Shohat, et al.

    In Table 5 the P value for the parameter “More than one chronic disease” is incorrect. The correct value is 0.387, not 0.0387.


  • Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study

    by Nasser Sakran, Shiri Sherf-Dagan, Orit Blumenfeld, Orly Romano-Zelekha, Asnat Raziel, Dean Keren, Itamar Raz, Dan Hershko, Ian M. Gralnek, Tamy Shohat, et al.

    Although bariatric surgery (BS) is considered safe, concern remains regarding severe post-operative adverse events and mortality. Using a national BS registry, the aim of this study was to assess the incidence, etiologies, and risk factors for mortality following BS.